Back

Epicardial adipose tissue Glucagon-like peptide-1 receptor upregulation in human atrial fibrillation might be functionally offset by accompanying Phosphodiesterase-4 upregulation

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Atrial imaging and outcomes Cell-Cell Interaction ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Anastasios Lymperopoulos

Nova Southeastern University, Fort Lauderdale (United States of America)

5 More presentations in this session

Presentation thumbnail
GLP-1 receptor agonists and risk of early and late recurrence after AF ablation in type 2 diabetes: an analysis from a global federated research network
Doctor L. Serio (L'Aquila, IT)
Abstract Slides
Presentation thumbnail
Prediction of incident atrial fibrillation from a 10-second single-lead ECG using a neural network
Mr B. Holderied (Greifswald, DE)
Abstract Slides
Presentation thumbnail
Predictive value of TGF-β1 for new-onset atrial fibrillation following coronary artery bypass grafting
Mr J. Li (Beijing, CN)
Abstract Slides
Presentation thumbnail
Association of female sex with adverse clinical events in patients with new-onset post-operative atrial fibrillation: insights from the VISION cardiac surgery cohort
Doctor W. McIntyre (Hamilton, CA)
Abstract Slides
Presentation thumbnail
Risk factors and electrocardiographic predictors associated with new-onset atrial fibrillation in hospitalized COVID-19 patients. Evaluation of a novel P-wave index.
Doctor P. Arvanitis (Uppsala, SE)
Abstract Slides

Access the full session

Session thumbnail
Atrial imaging and outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Role of epicardial adipose tissue in atrial cardiomyopathy: focus on fibrosis, amyloid deposition, and arrhythmogenesis
13 December 2025
thumbnail
ESC Journals
Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node
4 June 2024
thumbnail
Webinar
GLP-1 RAs and HFpEF: which HFpEF patients should now be receiving GLP-1 RAs?
15 December 2025
thumbnail
Congress Presentation
The pleiotropic effect of a deleterious DES mutation in familial atrial fibrillation and the role of PDE4DIP as a genetic modifier for heart block
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources